Drug Type Antibody |
Synonyms IKC 116P, IKC116P |
Target |
Mechanism VEGF inhibitors(Vascular endothelial growth factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ikarovec Ltd.Startup |
Active Organization Ikarovec Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Preclinical | GB | Ikarovec Ltd.Startup | 01 Jun 2022 |